Document:

Unassociated Document

    PLACEMENT
AGENCY AGREEMENT

     

    October
2, 2009

     

    Roth
Capital Partners, LLC

    24
Corporate Plaza

    Newport
Beach, CA  92660

    

    Ladies
and Gentlemen:

     

    China
Ritar Power Corp., a Nevada corporation (the “Company”), proposes,
subject to the terms and conditions stated herein, to issue and sell up to
2,150,000 shares (the “Shares”) of the
Company’s common stock, par value $0.001 per share (the “Common Stock”)
directly to various investors (the “Investors”) in a
transaction in which Roth Capital Partners, LLC (“Roth”) will act as
placement agent.

     

    The
Company and Roth hereby confirm their agreement as follows:

     

    1.           Agreement to Act
as Placement
Agent.  On the basis of
the representations, warranties and agreements of the Company herein contained,
and subject to all the terms and conditions of this Agreement, Roth shall serve
as the exclusive placement agent in connection with the issuance and sale by the
Company of the Shares from the Registration Statement (as defined in Section 2
below), with the terms of such offering (the “Offering”) to be
subject to market conditions and negotiations between the Company, Roth and the
Investors.  Roth shall act on a best efforts basis and does not
guarantee that it will be able to sell the Shares in the prospective
Offering.  As compensation for services rendered, on the Closing Date
(as defined below), the Company shall pay to Roth a cash fee in an amount equal
to 6% of the gross proceeds received by the Company from the sale of such
Shares.  The purchase price to the Investors for each Share is US$6.00
(the “Offering
Price”).  The term of Roth’s exclusive engagement will be five
(5) days from the date hereof (the “Exclusive
Term”).  Roth will be entitled to collect all fees earned
through termination.

     

    2.           Registration
Statement and Final Prospectus.  The Company has prepared and
filed with the Securities and Exchange Commission (the “Commission”) a
registration statement on Form S-3 (File No. 333-161281) under the Securities
Act of 1933, as amended (the “Securities Act”), and
the rules and regulations (the “Rules and
Regulations”) of the Commission thereunder, and such amendments to such
registration statement (including any post-effective amendments) as may have
been required to the date of this Agreement.  Such registration
statement, as amended (including any post-effective amendments), has been
declared effective by the Commission.  Such registration statement, as
amended (including any post-effective amendments), the exhibits and any
schedules thereto and the documents and information otherwise deemed to be a
part thereof or included therein by the Securities Act or otherwise pursuant to
the Rules and Regulations, is herein called the “Registration
Statement.”  If the Company has filed or files an abbreviated
registration statement pursuant to Rule 462(b) under the Securities Act (the
“Rule 462 Registration
Statement”), then any reference herein to the term Registration Statement
shall include such Rule 462 Registration Statement.  The Company will
file with the Commission pursuant to Rule 424 under the Securities Act a
prospectus supplement relating to the Shares to the form of prospectus included
in the Registration Statement.  Such prospectus in the form in which
it appears in the Registration Statement is hereinafter called the “Base Prospectus,” and
the final prospectus supplement as filed, along with the Base Prospectus, is
hereinafter called the “Final
Prospectus.”

    
      
         

      

      
        1

        
          

        

      

      
         

      

    

    For
purposes of this Agreement, all references to the Registration Statement, the
Rule 462 Registration Statement, the Base Prospectus, the Final Prospectus, or
any amendment or supplement to any of the foregoing shall be deemed to include
the copy filed with the Commission pursuant to its Interactive Data Electronic
Applications system.  All references in this Agreement to amendments
or supplements to the Registration Statement, the Rule 462 Registration
Statement, the Base Prospectus, or the Final Prospectus shall be deemed to mean
and include the subsequent filing of any document under the Securities Exchange
Act of 1934, as amended (the “Exchange Act”), that
is deemed to be incorporated therein by reference or otherwise deemed by the
Rules and Regulations to be a part thereof.

     

    3.           Representations
and Warranties Regarding the Offering.

     

    (a)           The
Company represents and warrants to, and agrees with, Roth, as of the date hereof
and as of the Closing Date, except as otherwise indicated, as
follows:

     

    (i)           At
the time of effectiveness, at the date hereof and at the Closing Date, the
Registration Statement complied or will comply in all material respects with the
requirements of the Securities Act and the Rules and Regulations and did not and
will not contain any untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements
therein not misleading.  The Time of Sale Disclosure Package (as
defined below) as of the date hereof and at the Closing Date, and the Final
Prospectus, as amended or supplemented, at the time of filing pursuant to Rule
424(b) under the Securities Act and at the Closing Date, did not and will not
contain any untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements therein, in
the light of the circumstances under which they were made, not
misleading.  The representations and warranties set forth in the two
immediately preceding sentences shall not apply to statements in or omissions
from the Registration Statement or any post-effective amendment thereto or the
Final Prospectus in reliance upon, and in conformity with, written information
furnished to the Company by Roth specifically for use in the preparation
thereof.  The Registration Statement contains all exhibits and
schedules required to be filed by the Securities Act or the Rules and
Regulations.  No order preventing or suspending the effectiveness or
use of the Registration Statement or the Final Prospectus is in effect and no
proceedings for such purpose have been instituted or are pending, or, to the
knowledge of the Company, are threatened in writing by the
Commission.

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

    (ii)          The
documents incorporated by reference in the Registration Statement, the Time of
Sale Disclosure Package and the Final Prospectus, when they became effective or
were filed with the Commission, as the case may be, conformed in all material
respects to the requirements of the Securities Act or the Exchange Act, as
applicable, were filed on a timely basis with the Commission and none of such
documents, when they were filed (or, if amendments to such documents were filed,
when such amendments were filed), contained an untrue statement of a material
fact or omitted to state a material fact necessary to make the statements
therein, in the light of the circumstances under which they were made, not
misleading.  Any further documents so filed and incorporated by
reference in the Registration Statement, the Time of Sale Disclosure Package or
the Final Prospectus, when such documents are filed with the Commission, will
conform in all material respects to the requirements of the Exchange Act, and
will not contain an untrue statement of a material fact or omit to state a
material fact necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading.  As used in
this paragraph and elsewhere in this Agreement, “Time of Sale Disclosure
Package” means the Final Prospectus, any subscription agreement between
the Company and the Investors, and any issuer free writing prospectus as defined
in Rule 433 of the Act (each, an “Issuer Free Writing
Prospectus”), if any, identified in Schedule I hereto, that the
parties hereto shall hereafter expressly agree in writing to treat as part of
the Disclosure Package.

     

    (iii)         The
financial statements of the Company, together with the related notes, included
or incorporated by reference in the Registration Statement, the Time of Sale
Disclosure Package and the Final Prospectus comply in all material respects with
the requirements of the Securities Act and the Exchange Act and fairly present
in all material respects the financial condition of the Company as of the dates
indicated and the results of operations and changes in cash flows for the
periods therein specified in conformity with generally accepted accounting
principles consistently applied throughout the periods involved; and the
supporting schedules included in the Registration Statement present fairly in
all material respects the information required to be stated
therein.  No other financial statements or schedules are required to
be included in the Registration Statement, the Time of Sale Disclosure Package
or the Final Prospectus.  To the Company’s knowledge, AGCA, Inc. and
Child, Van Wagoner & Bradshaw, PLLC are independent public accounting firms
with respect to the Company within the meaning of the Securities Act and the
Rules and Regulations.

     

    (iv)         The
Company had a reasonable basis for, and made in good faith, each
“forward-looking statement” (within the meaning of Section 27A of the Act or
Section 21E of the Exchange Act) contained or incorporated by reference in the
Registration Statement, the Time of Sale Disclosure Package or the Final
Prospectus.

     

    (v)          All
statistical or market-related data included or incorporated by reference in the
Registration Statement, the Time of Sale Disclosure Package or the Final
Prospectus are based on or derived from sources that the Company reasonably
believes to be reliable and accurate, and the Company has obtained the written
consent to the use of such data from such sources, to the extent
required.

     

    (vi)         To
the knowledge of the Company, there is no action pending to delist the Common
Shares from the NASDAQ Global Market (“NASDAQ Global
Market”), nor has the Company received any written notification that the
NASDAQ Global Market is currently contemplating terminating such
listing.  When issued, the Shares will be listed on the NASDAQ Global
Market.

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

    (vii)        The
Shares have been or will be qualified for sale under the securities laws of such
United States jurisdictions as Roth reasonably determines, or are or will be
exempt from the qualification requirements of such jurisdictions; provided that
the Company shall not be required to (A) qualify as a foreign corporation or
other entity or as a dealer in securities in any such jurisdiction where it
would not otherwise be required to so qualify, (B) file any general consent to
service of process in any such jurisdiction, or (C) subject itself to taxation
in any such jurisdiction if it is not otherwise so subject.

     

    (viii)       The
Company has not taken, directly or indirectly, any action that is designed to or
that has constituted or that would reasonably be expected to cause or result in
the stabilization or manipulation of the price of any security of the Company to
facilitate the sale of the Shares.

     

    (ix)          The
Company is not an “ineligible issuer,”
as defined in Rule 405 of the Securities Act.  Subject to Section 6(d)
below, the Company represents and warrants that it has not prepared or had
prepared on its behalf or used or referred to any Issuer Free Writing Prospectus
in connection with the Offering.  Subject to Section 6(d) below, the
Company has not distributed and the Company will not distribute, prior to the
completion of the distribution of the Shares, any offering material in
connection with the Offering other than subscription agreements between the
Company and the Investors and the Base Prospectus, the Final Prospectus, the
Registration Statement, and copies of the documents, if any, incorporated by
reference therein.

     

    (x)           The
Company is not and, after giving effect to the offering and sale of the Shares,
will not be required to register as an “investment company,” as such term is
defined in the Investment Company Act of 1940, as amended.

     

    (b)           Any
certificate signed by any officer of the Company and delivered to Roth or to
Roth’s counsel in connection with this Offering shall be deemed a representation
and warranty by the Company to Roth as to the matters covered
thereby.

     

    4.           Representations
and Warranties Regarding the Company.

     

    (a)           The
Company represents and warrants to and agrees with, Roth, except as set forth in
the Registration Statement, the Time of Sale Disclosure Package and the Final
Prospectus, as follows:

     

    (i)           The
Company and each of its subsidiaries has been duly organized and is validly
existing as a corporation in good standing under the laws of its jurisdiction of
incorporation. The Company and each of its subsidiaries has the corporate power
and authority to own its properties and conduct its business as currently being
carried on and as described in the Registration Statement, the Time of Sale
Disclosure Package and the Final Prospectus, and is duly qualified to do
business as a foreign corporation in good standing in each jurisdiction in which
it owns or leases real property or in which the conduct of its business makes
such qualification necessary and in which the failure to so qualify would have
or is reasonably likely to result in a material adverse effect upon the
business, properties, operations, condition (financial or otherwise) or results
of operations of the Company and its subsidiaries, taken as a whole, or in its
ability to perform its obligations under this Agreement (“Material Adverse
Effect”).

     

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

    (ii)          The
Company has the corporate power and authority to enter into this
Agreement.  This Agreement has been duly authorized, executed and
delivered by the Company, and constitutes a valid, legal and binding obligation
of the Company, enforceable in accordance with its terms, except as rights to
indemnity hereunder may be limited by federal or state laws and except as such
enforceability may be limited by bankruptcy, insolvency, reorganization or
similar laws affecting the rights of creditors generally and subject to general
principles of equity.

     

    (iii)         The
execution, delivery and performance of this Agreement and the consummation of
the transactions herein contemplated will not (A) result in a breach or
violation of any of the terms and provisions of, or constitute a default under,
any law, rule or regulation to which the Company or any subsidiary is subject,
or by which any property or asset of the Company or any subsidiary is bound or
affected, (B) conflict with, result in any violation or breach of, or constitute
a default (or an event that with notice or lapse of time or both would become a
default) under, or give to others any right of termination, amendment,
acceleration or cancellation (with or without notice, lapse of time or both) of,
any agreement, lease, credit facility, debt, note, bond, mortgage, indenture or
other instrument or binding obligation or other binding understanding (the
“Contracts”) to
which the Company or any subsidiary is a party of by which any property or asset
of the Company or any subsidiary is bound or affected, or (C) result in a breach
or violation of any of the terms and provisions of, or constitute a default
under, the Company’s charter or bylaws, except in the case of clauses (A)
and (B) such breaches, violations, defaults, or conflicts which do not
individually or in the aggregate be reasonably likely to result in a Material
Adverse Effect.

     

    (iv)         All
consents, approvals, orders, authorizations and filings required on the part of
the Company and its subsidiaries in connection with the execution, delivery or
performance of this Agreement have been obtained or made, other than such
consents, approvals, orders and authorizations the failure of which to make or
obtain is not reasonably likely to result in a Material Adverse
Effect.

     

    (v)          All
of the issued and outstanding shares of capital stock of the Company are duly
authorized and validly issued, fully paid and nonassessable, and have been
issued in material compliance with all applicable securities laws, and conform
in all material respects to the description thereof in the Registration
Statement, the Time of Sale Disclosure Package and the Final
Prospectus.  Except for the issuances of options or restricted stock
or restricted stock units in the ordinary course of business, since the
respective dates as of which information is provided in the Registration
Statement, the Time of Sale Disclosure Package or the Final Prospectus, the
Company has not entered into or granted any convertible or exchangeable
securities, options, warrants, agreements, contracts or other rights in
existence to purchase or acquire from the Company any shares of the capital
stock of the Company.  The Shares, when issued, will be duly
authorized and validly issued, fully paid and nonassessable, issued in material
compliance with all applicable securities laws, and free of preemptive,
registration or similar rights.

     

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

    (vi)         Except
as set forth in the Registration Statement, the Time of Sale Disclosure Package
and the Final Prospectus, the Company does not own, directly or indirectly, a
majority of the capital stock or other ownership interest in any partnership,
corporation, business trust, limited liability company, limited liability
partnership, joint stock company, trust, unincorporated association, joint
venture or other entity.

     

    (vii)        Each
of the Company and its subsidiaries has filed all foreign, federal, state and
local returns (as hereinafter defined) required to be filed with taxing
authorities prior to the date hereof or has duly obtained extensions of time for
the filing thereof.  Each of the Company and its subsidiaries has paid
all taxes (as hereinafter defined) shown as due on such returns that were filed
and has paid all taxes imposed on or assessed against the Company or such
respective subsidiary.  The term “taxes” mean all
federal, state, local, foreign, and other net income, gross income, gross
receipts, sales, use, ad valorem, transfer, franchise, profits, license, lease,
service, service use, withholding, payroll, employment, excise, severance,
stamp, occupation, premium, property, windfall profits, customs, duties or other
taxes, fees, assessments, or charges of any kind whatever, together with any
interest and any penalties, additions to tax, or additional amounts with respect
thereto.  The term “returns” means all
returns, declarations, reports, statements, and other documents required to be
filed in respect to taxes.

     

    (viii)       Since
the respective dates as of which information is given in the Registration
Statement, the Time of Sale Disclosure Package or the Final Prospectus, (a)
neither the Company nor any of its subsidiaries has incurred any material
liabilities or obligations, direct or contingent, required to be reflected on a
balance sheet in accordance with generally accepted accounting principles, or
entered into any material transactions other than in the ordinary course of
business, (b) the Company has not declared or paid any dividends or made any
distribution of any kind with respect to its capital stock; (c) there has not
been any change in the capital stock of the Company or any of its subsidiaries
(other than a change in the number of outstanding shares of Common Stock due to
the issuance of shares upon the exercise of outstanding options or warrants or
the issuance of restricted stock awards or restricted stock units under the
Company’s existing stock awards plan, or any new grants thereof in the
ordinary course of business), (d) there has not been any material change in the
Company’s long-term or short-term debt, and (e) there has not been the
occurrence of any Material Adverse Effect.

     

    (ix)          There
is not pending or, to the knowledge of the Company, threatened, any action, suit
or proceeding to which the Company or any of its subsidiaries is a party or of
which any property or assets of the Company is the subject before or by any
court or governmental agency, authority or body, or any arbitrator or mediator,
which is reasonably likely to result in a Material Adverse Effect.

     

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

    (x)           The
Company and each of its subsidiaries holds, and is in compliance with, all
franchises, grants, authorizations, licenses, permits, easements, consents,
certificates and orders (“Permits”) of any
governmental or self-regulatory agency, authority or body required for the
conduct of its business, and all such Permits are in full force and effect, in
each case except where the failure to hold, or comply with, any of them is not
reasonably likely to result in a Material Adverse Effect.

     

    (xi)          The
Company and its subsidiaries have good and marketable title to all property
(whether real or personal) described in the Registration Statement, the Time of
Sale Disclosure Package and the Final Prospectus as being owned by them that are
material to the business of the Company, in each case free and clear of all
liens, claims, security interests, other encumbrances or defects, except those
that are not reasonably likely to result in a Material Adverse
Effect.  The property held under lease by the Company and its
subsidiaries is held by them under valid, subsisting and enforceable leases with
only such exceptions with respect to any particular lease as do not interfere in
any material respect with the conduct of the business of the Company or its
subsidiaries.

     

    (xii)         The
Company and each of its subsidiaries owns or possesses or has valid right to use
all patents, patent applications, trademarks, service marks, trade names,
trademark registrations, service mark registrations, copyrights, licenses,
inventions, trade secrets and similar rights (“Intellectual
Property”) necessary for the conduct of the business of the Company and
its subsidiaries as currently carried on and as described in the Registration
Statement, the Time of Sale Disclosure Package and the Final Prospectus, except
those the absence of which are not reasonably likely to result in a Material
Adverse Effect.  To the knowledge of the Company, no action or use by
the Company or any of its subsidiaries will involve or give rise to any
infringement of, or license or similar fees for, any Intellectual Property of
others, except where such action, use, license or fee is not reasonably likely
to result in a Material Adverse Effect.  Neither the Company nor any
of its subsidiaries has received any written notice alleging any such material
infringement or fee.

     

    (xiii)        The
Company and each of its subsidiaries has complied with, is not in violation of,
and has not received any written notice of violation relating to any applicable
law, rule or regulation relating to the conduct of its business, or the
ownership or operation of its property and assets, including, without limitation
(to the extent applicable), (A) the Currency and Foreign Transactions Reporting
Act of 1970, as amended, or any money laundering laws, rules or regulations, (B)
any laws, rules or regulations related to health, safety or the environment,
including those relating to the regulation of hazardous substances, (C) the
Sarbanes-Oxley Act and the rules and regulations of the Commission thereunder,
(D) the Foreign Corrupt Practices Act of 1977 and the rules and regulations
thereunder, and (E) the Employment Retirement Income Security Act of 1974 and
the rules and regulations thereunder, in each case except where the failure to
be in compliance is not reasonably likely to result in a Material Adverse
Effect.

     

    (xiv)       Neither
the Company nor any of its subsidiaries nor, to the knowledge of the Company,
any director, officer, employee, representative, agent or affiliate of the
Company or any of its subsidiaries is currently subject to any U.S. sanctions
administered by the Office of Foreign Assets Control of the U.S. Treasury
Department (“OFAC”); and the
Company will not directly or indirectly use the proceeds of the Offering of the
Shares contemplated hereby, or lend, contribute or otherwise make available such
proceeds to any person or entity, for the purpose of financing the activities of
any person currently subject to any U.S. sanctions administered by
OFAC.

     

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

    (xv)       The
Company and each of its subsidiaries carries, or is covered by, insurance in
such amounts and covering such risks as is customary for companies engaged in
similar businesses in similar industries.

     

    (xvi)       No
labor dispute with the employees of the Company or any of its subsidiaries
exists or, to the knowledge of the Company, is imminent that is reasonably
likely to result in a Material Adverse Effect.

     

    (xvii)      Neither
the Company nor any of its subsidiaries is in violation, breach or default under
its certificate of incorporation, bylaws or other equivalent organizational or
governing documents, except where the violation is not reasonably likely to
result in a Material Adverse Effect. 

     

    (xviii)     Neither
the Company, its subsidiaries nor, to its knowledge, any other party is in
violation, breach or default of any Contract that is reasonably likely to result
in a Material Adverse Effect.

     

    (xix)       No
supplier, customer, distributor or sales agent of the Company
has notified the Company that it  intends to discontinue
or decrease the rate of business done with the Company, except
where such discount or decrease is not reasonably likely to result in a Material
Adverse Effect.

     

    (xx)         All
consents, approvals, authorizations or licenses requisite under the legal
requirements of the People’s Republic of China, not including Taiwan, Hong Kong
and Macau (“PRC”) for the due and
proper establishment and operation of the Company and its subsidiaries have been
duly obtained from the relevant PRC governmental bodies and are in full force
and effect; except where the failure to obtain any such consent, approval,
authorization or license or maintain the same in full force and effect would not
have, or be reasonably likely to result in, a Material Adverse
Effect.

     

    (xxi)        All filings
and registrations with the PRC governmental bodies required in respect of the
Company and its subsidiaries and their capital structure and operations
including, without limitation, the registration with the Ministry of Commerce,
the China Securities Regulatory Commission, the State Administration of
Industry, or their respective local divisions of Commerce, the State
Administration of Foreign Exchange, tax bureau and customs authorities have been
duly completed in accordance with the relevant PRC legal requirements, except
where, the failure to complete such filings and registrations does not, and
would not, individually or in the aggregate, have a Material Adverse
Effect.

     

    (xxii)       The
Company and its subsidiaries have complied with all relevant PRC legal
requirements regarding the contribution and payment of its registered share
capital, the payment schedule of which has been approved by the relevant PRC
governmental bodies.  There are no outstanding commitments made by the
Company or any subsidiary (or any of their shareholders) to sell any equity
interest in the Company or any subsidiary.

     

    
      
         

      

      
        8

        
          

        

      

      
         

      

    

    (xxiii)      Neither
the Company nor any subsidiary has received any letter or notice from any
relevant PRC governmental body notifying it of revocation of any licenses or
qualifications issued to it or any subsidy granted to it by any PRC governmental
body for non-compliance with the terms thereof or with applicable PRC legal
requirements, or the lack of compliance or remedial actions in respect of the
activities carried out by the Company or any subsidiary, except such revocation
as does not, and would not, individually or in the aggregate, have a Material
Adverse Effect.

     

    (xxiv)     The
Company and its subsidiaries have conducted their business activities within the
permitted scope of business or have otherwise operated their business in
compliance with all relevant legal requirements and with all requisite licenses
and approvals granted by competent PRC governmental bodies other than such
non-compliance that do not, and would not, individually or in the aggregate,
have a Material Adverse Effect.  As to licenses, approvals and
government grants and concessions requisite or material for the conduct of any
material part of the Company or subsidiaries’ business which is subject to
periodic renewal, the Company has no knowledge of any reasons for which such
requisite renewals will not be granted by the relevant PRC governmental
bodies.

     

    (xxv)      With
regard to employment and staff or labor, the Company and its subsidiaries have
complied with all applicable PRC legal requirements in all material respects,
including, without limitation, those pertaining to welfare funds, social
benefits, medical benefits, insurance, retirement benefits, pensions or the
like, other than such non-compliance that does not, and would not, individually
or in the aggregate, have a Material Adverse Effect.

     

    (xxvi)     There
are no claims, payments, issuances, arrangements or understandings for services
in the nature of a finder’s, consulting or origination fee with respect to the
introduction of the Company to Roth or the sale of the Shares hereunder or
any other arrangements, agreements, understandings, payments or issuances with
respect to the Company to which the Company is a party that, to the knowledge of
the Company, will affect Roth’s compensation, as determined by
FINRA.

     

    (xxvii)    Except
as disclosed to Roth in writing, the Company has not made any direct or indirect
payments (in cash, securities or otherwise) to (i) any person, as a finder’s
fee, investing fee or otherwise, in consideration of such person raising capital
for the Company or introducing to the Company persons who provided capital to
the Company, (ii) any FINRA member, or (iii) any person or entity that has any
direct or indirect affiliation or association with any FINRA member within the
12-month period prior to the date on which the Registration Statement was filed
with the Commission (“Filing Date”) or
thereafter.

     

    
      
         

      

      
        9

        
          

        

      

      
         

      

    

    (xxviii)    To
the Company’s knowledge, no (i) officer or director of the Company or its
subsidiaries, (ii) owner of 5% or more of the Company’s unregistered securities
or that of its subsidiaries or (iii) owner of any amount of the Company’s
unregistered securities acquired within the 180-day period prior to the Filing
Date, has any direct or indirect affiliation or association with any FINRA
member.

     

    (xxix)      Other
than Roth, no person has the right to act as a placement agent, underwriter or
as a financial advisor in connection with the Offering contemplated
hereby.

     

    5.           Closing and
Settlement.  Subject to the
terms and conditions hereof, payment of the purchase price for, and delivery of,
the Shares shall be made at one or more closings (each a “Closing” and the date
on which each Closing occurs, a “Closing Date”) at the
offices of Winston & Strawn LLP (counsel to Roth), with an office located at
200 Park Avenue, New York, NY 10166 (or at such other place as shall be
agreed upon by Roth and the Company), the first such Closing to take place at
6:00 a.m., Pacific Daylight time, on October 8, 2009 (unless another time shall
be agreed to by Roth and the Company). On the
trading day following the date of this Agreement, and prior to the Closing Date,
each Investor will confirm their purchase price and the number of Shares they
have purchased with their custodian bank or prime broker.  On the
Closing Date (i) the Investor will provide their purchase price by delivery of
immediately available funds versus receipt of their Shares through such
Investor’s executing broker’s delivery versus payment account set up at Roth,
(ii) the Company will deliver, or cause to be delivered, to Roth, the aggregate
number of Shares purchased by Investors by authorizing the release of the Shares
to Roth’s clearing firm, Ridge Clearing & Outsourcing Solutions DTC 0158 via
DWAC delivery prior to the release of the federal funds wire to the Company for
payment of such Shares, (iii) Roth will deliver, or cause to be delivered, to
each Investor, such Investor’s Shares in accordance with the instructions
provided by such Investor on their executing broker’s account versus payment for
such Shares and (iv) Roth will deliver, or cause to be delivered, to the
Company, the aggregate purchase price of all Investors, minus applicable fees
and disbursements.

     

    6.           Covenants.  The
Company covenants and agrees with Roth as follows:

     

    (a)           During
the period beginning on the date hereof and ending on the Closing Date (the
“Prospectus Delivery
Period”), prior to amending or supplementing the Registration Statement,
including any Rule 462 Registration Statement, the Time of Sale Disclosure
Package or the Final Prospectus, the Company shall furnish to Roth for review
and comment a copy of each such proposed amendment or supplement, and the
Company shall not file any such proposed amendment or supplement to which Roth
promptly and reasonably objects.

     

    (b)           From
the date of this Agreement until the end of the Prospectus Delivery Period, the
Company shall promptly advise Roth in writing (A) of the receipt of any comments
of, or requests for additional or supplemental information from, the Commission,
(B) of the time and date of any filing of any post-effective amendment to the
Registration Statement or any amendment or supplement to the Time of Sale
Disclosure Package or the Final Prospectus, (C) of the time and date that any
post-effective amendment to the Registration Statement becomes effective and (D)
of the issuance by the Commission of any stop order suspending the effectiveness
of the Registration Statement or of any order preventing or suspending its use
or the use of the Time of Sale Disclosure Package, or of any proceedings to
remove, suspend or terminate from listing or quotation the Common Stock from any
securities exchange upon which it is listed for trading or included or
designated for quotation, or of the threatening or initiation of any proceedings
for any of such purposes.  If the Commission shall enter any such stop
order at any time during the Prospectus Delivery Period, the Company will use
its reasonable efforts to obtain the lifting of such order at the earliest
practicable time.  Additionally, the Company agrees that it shall
comply with the provisions of Rules 424(b), 430A and 430B, as applicable to the
Offering, under the Securities Act and will use its reasonable efforts to
confirm that any filings made by the Company under Rule 424(b) or Rule 433 were
received in a timely manner by the Commission (without reliance on Rule
424(b)(8) or Rule 164(b) of the Securities Act).

     

    
      
         

      

      
        10

        
          

        

      

      
         

      

    

    (c)           During
the Prospectus Delivery Period, the Company will comply with all requirements
imposed upon it by the Securities Act, as now and hereafter amended, and by the
Rules and Regulations, as from time to time in force, and by the Exchange Act,
as now and hereafter amended, so far as necessary to permit the continuance of
sales of or dealings in the Shares as contemplated by the provisions hereof, the
Registration Statement, the Time of Sale Disclosure Package and the Final
Prospectus.  If during such period any event occurs the result of
which the Final Prospectus would include an untrue statement of a material fact
or omit to state a material fact necessary to make the statements therein, in
the light of the circumstances then existing, not misleading, or if during such
period it is reasonably necessary or appropriate in the opinion of the Company
or its counsel or Roth or its counsel to amend the Registration Statement or
supplement the Final Prospectus to comply with the Securities Act, the Company
will promptly notify Roth and will amend the Registration Statement or
supplement the Final Prospectus so as to correct such statement or omission or
effect such compliance.

     

    (d)           The
Company covenants that it will not, unless it obtains the prior written consent
of Roth, make any offer relating to the Securities that would constitute an
Issuer Free Writing Prospectus or that would otherwise constitute a “free writing
prospectus” (as defined in Rule 405 of the Act) required to be filed by
the Company with the Commission or retained by the Company under Rule 433 of the
Act.  In the event that Roth expressly consents in writing to any such
free writing prospectus (a “Permitted Free Writing
Prospectus”), the Company covenants that it shall (i) treat each
Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii)
comply with the requirements of Rule 164 and 433 of the Act applicable to such
Permitted Free Writing Prospectus, including in respect of timely filing with
the Commission, legending and record keeping.

     

    (e)           The
Company will furnish to Roth and counsel for Roth copies of the Registration
Statement, the Final Prospectus and all amendments and supplements to such
documents, in each case as soon as practicable and in such quantities as Roth
may from time to time reasonably request.

     

    (f)           The
Company will not take, directly or indirectly, during the Prospectus Delivery
Period, any action designed to or which might reasonably be expected to cause or
result in, or that has constituted, the stabilization or manipulation of the
price of any security of the Company to facilitate the sale or resale of the
Shares.

     

    (g)           The
Company, whether or not the transactions contemplated hereunder are consummated
or this Agreement is terminated, will pay or cause to be paid  (A) all
documented, out of pocket expenses (including transfer taxes allocated to the
respective transferees) incurred in connection with the delivery of the Shares,
including the reasonable legal fees of Roth’s counsel, up to a maximum amount of
$50,000 for all such expenses and fees, (B) all expenses and fees (including,
without limitation, fees and expenses of the Company’s counsel) in connection
with the preparation, printing, filing, delivery, and shipping of the
Registration Statement (including the financial statements therein and all
amendments, schedules, and exhibits thereto), the Shares, the Time of Sale
Disclosure Package, the Final Prospectus, any Issuer Free Writing Prospectus and
any amendment thereof or supplement thereto, (C) the fees and expenses of any
transfer agent or registrar, (D) listing fees, if any, and (E) all other costs
and expenses of the Company incident to the performance of its obligations
hereunder that are not otherwise specifically provided for herein.

     

    
      
         

      

      
        11

        
          

        

      

      
         

      

    

    (h)           The
Company will not issue or sell any Common Stock or other equity or equity-linked
securities (excluding the conversion or exercise of any securities outstanding
on the date hereof and the issuance of any securities pursuant to compensatory
plans) for a period of fifteen days following the date hereof, unless Roth
consents otherwise.

     

    7.           Conditions of
Roth’s Obligations.  The obligations of Roth hereunder are
subject to the accuracy, as of the date hereof and at the applicable Closing
Date (as if made at the Closing Date), of and compliance with all
representations, warranties and agreements of the Company contained herein, the
performance by the Company of its obligations hereunder and the following
additional conditions:

     

    (a)           If
filing of the Final Prospectus, or any amendment or supplement thereto, is
required under the Securities Act or the Rules and Regulations, the Company
shall have filed the Final Prospectus (or such amendment or supplement) with the
Commission in the manner and within the time period so required (without
reliance on Rule 424(b)(8) or Rule 164(b) under the Securities Act); the
Registration Statement shall remain effective; no stop order suspending the
effectiveness of the Registration Statement or any part thereof, any Rule 462
Registration Statement, or any amendment thereof, nor suspending or preventing
the use of the Time of Sale Disclosure Package or the Final Prospectus shall
have been issued; no proceedings for the issuance of such an order shall have
been initiated or threatened; any request of the Commission for additional
information (to be included in the Registration Statement, the Time of Sale
Disclosure Package, the Final Prospectus, or otherwise) shall have been complied
with to Roth’s reasonable satisfaction.

     

    (b)           The
Registration Statement, the Time of Sale Disclosure Package or the Final
Prospectus, or any amendment thereof or supplement thereto, shall not contain an
untrue statement of fact, or omit to state a fact which is required to be stated
therein or necessary to make the statements therein not misleading.

     

    (c)           On
the applicable Closing Date, there shall have been furnished to Roth the opinion
and negative assurance letters of counsel for the Company, dated the applicable
Closing Date and addressed to Roth, in form and substance reasonably
satisfactory to Roth, to the effect set forth in Schedule III.

     

    (d)           Roth
shall have received a letter from each of AGCA, Inc. and Child, Van Wagoner
& Bradshaw, PLLC, on the applicable Closing Date addressed to Roth,
confirming that they are independent public accountants within the meaning of
the Securities Act and are in compliance with the applicable requirements
relating to the qualifications of accountants under Rule 2-01 of Regulation S-X
of the Commission, and confirming, as of the date of each such letter (or, with
respect to matters involving changes or developments since the respective dates
as of which specified financial information is given in the Time of Sale
Disclosure Package, as of a date not more than five days prior to the date of
such letter), the conclusions and findings of said firms with respect to the
financial information, including any financial information contained in Exchange
Act Reports filed by the Company, and other matters reasonably required by Roth
consistent with customary practice for such letters.

     

    
      
         

      

      
        12

        
          

        

      

      
         

      

    

    (e)           On
the applicable Closing Date, there shall have been furnished to Roth a
certificate, dated the applicable Closing Date and addressed to Roth, signed by
the chief executive officer and the chief financial officer of the Company,
solely in their capacity as officers of the Company, to the effect
that:

     

    (i)           The
representations and warranties of the Company in this Agreement are true and
correct, in all material respects, as if made at and as of the applicable
Closing Date, and the Company has complied with all the agreements and satisfied
all the conditions on its part to be performed or satisfied at or prior to the
applicable Closing Date;

     

    (ii)           No
stop order or other order (A) suspending the effectiveness of the Registration
Statement or any part thereof or any amendment thereof, (B) suspending the
qualification of the Shares for offering or sale, or (C) suspending or
preventing the use of the Time of Sale Disclosure Package or the Final
Prospectus has been issued, and no proceeding for that purpose has been
instituted or, to their knowledge, is threatened in writing by the Commission or
any state or regulatory body; and

     

    (iii)           There
has been no occurrence of any event resulting or reasonably likely to result in
a Material Adverse Effect during the period from and after the date of this
Agreement and prior to the applicable Closing Date.

     

    (f)           The
Common Stock shall be registered under the Exchange Act and shall be listed on
the NASDAQ Global Market, and the Company shall not have taken any action
designed to terminate, or likely to have the effect of terminating, the
registration of the Common Stock under the Exchange Act or delisting or
suspending from trading the Common Stock from the NASDAQ Global Market, nor
shall the Company have received any written notice that the NASDAQ Global Market
is contemplating terminating such registration or listing.

     

    (g)          The
Company shall have furnished to Roth and counsel for Roth such additional
documents, certificates and evidence as Roth or counsel for Roth may have
reasonably requested.

     

    If any condition specified in this
Section 7 shall not have been fulfilled when and as required to be fulfilled,
this Agreement may be terminated by Roth by notice to the Company at any time at
or prior to the applicable Closing Date and such termination shall be without
liability of any party to any other party, except that the second to last
sentence of Section 1, Section 6(h), Section 8 and Section 9 shall survive any
such termination and remain in full force and effect.

     

    
      
         

      

      
        13

        
          

        

      

      
         

      

    

    8.           Indemnification
and Contribution.

     

    (a)           The
Company agrees to indemnify, defend and hold harmless Roth,
its  affiliates, directors and officers and employees, and each
person, if any, who controls Roth within the meaning of Section 15 of the
Securities Act or Section 20 of the Exchange Act, from and against any
losses, claims, damages or liabilities to which Roth or such person may become
subject, under the Securities Act or otherwise (including in settlement of any
litigation if such settlement is effected with the written consent of the
Company), insofar as such losses, claims, damages or liabilities (or actions in
respect thereof) arise out of or are based upon (i) an untrue statement or
alleged untrue statement of a material fact contained in the Registration
Statement, including the information deemed to be a part of the Registration
Statement at the time of effectiveness and at any subsequent time pursuant to
Rules 430A and 430B of the Rules and Regulations, the Time of Sale Disclosure
Package, the Final Prospectus, or any amendment or supplement thereto (including
any documents filed under the Exchange Act and deemed to be incorporated by
reference into the Registration Statement or the Final Prospectus), or any
Issuer Free Writing Prospectus or in any materials or information provided
to Investors by, or with the written approval of, the Company in connection with
the marketing of the Offering of the Shares, including any roadshow or investor
presentations (whether in person or electronically) (“Marketing
Materials”), or arise out of or are based upon the omission or alleged
omission to state therein a material fact required to be stated therein or
necessary to make the statements therein, in light of the circumstances under
which they were made, not misleading, or (ii) in whole or in part, any failure
of the Company to perform its obligations hereunder or under applicable law, and
will reimburse Roth for any reasonable, documented, out of pocket legal or other
expenses reasonably incurred by it in connection with evaluating, investigating
or defending against such loss, claim, damage, liability or action; provided, however, that the
Company shall not be liable in any such case to the extent that any such loss,
claim, damage, liability or action arises out of or is based upon an untrue
statement or alleged untrue statement or omission or alleged omission made in
the Registration Statement, the Time of Sale Disclosure Package, the Final
Prospectus, or any amendment or supplement thereto, any Issuer Free Writing
Prospectus or any Marketing Materials, in reliance upon and in conformity with
written information furnished to the Company by Roth specifically for use in the
preparation thereof.

     

    (b)           Roth
will indemnify and hold harmless the Company, its affiliates, directors,
officers and employees, and each person, if any, who controls the Company
or such person within the meaning of Section 15 of the Securities Act or Section
20 of the Exchange Act, from and against any losses, claims, damages or
liabilities to which the Company may become subject, under the Securities Act or
otherwise (including in settlement of any litigation, if such settlement is
effected with the written consent of such Roth), insofar as such losses, claims,
damages or liabilities (or actions in respect thereof) arise out of or are based
upon an untrue statement or alleged untrue statement of a material fact
contained in the Registration Statement, the Time of Sale Disclosure Package,
the Final Prospectus, or any amendment or supplement thereto, any Issuer Free
Writing Prospectus or any Marketing Materials, or arise out of or are based upon
the omission or alleged omission to state therein a material fact required to be
stated therein or necessary to make the statements therein not misleading, in
each case to the extent, but only to the extent, that such untrue statement or
alleged untrue statement or omission or alleged omission was made in the
Registration Statement, the Time of Sale Disclosure Package, the Final
Prospectus, or any amendment or supplement thereto, any Issuer Free Writing
Prospectus or any Marketing Materials, in reliance upon and in conformity with
written information furnished to the Company by Roth specifically for use in the
preparation thereof, and will reimburse the Company for any reasonable,
documented, out of pocket legal or other expenses reasonably incurred by the
Company in connection with defending against any such loss, claim, damage,
liability or action.

     

    
      
         

      

      
        14

        
          

        

      

      
         

      

    

    Promptly
after receipt by an indemnified party under subsection (a) or (b), above of
notice of the commencement of any action, such indemnified party shall, if a
claim in respect thereof is to be made against the indemnifying party under such
subsection, notify the indemnifying party in writing of the commencement
thereof; but the failure to notify the indemnifying party shall not relieve the
indemnifying party from any liability that it may have to any indemnified party
except to the extent such indemnifying party has been materially prejudiced by
such failure.  In case any such action shall be brought against any
indemnified party, and it shall notify the indemnifying party of the
commencement thereof, the indemnifying party shall be entitled to participate
in, and, to the extent that it shall wish, jointly with any other indemnifying
party similarly notified, to assume the defense thereof, with counsel
satisfactory to such indemnified party, and after notice from the indemnifying
party to such indemnified party of the indemnifying party’s election so to
assume the defense thereof, the indemnifying party shall not be liable to such
indemnified party under such subsection for any legal or other expenses
subsequently incurred by such indemnified party in connection with the defense
thereof other than reasonable, documented, out of pocket costs of investigation;
provided, however, that if (i) the
indemnified party has reasonably concluded (based on advice of counsel) that
there may be legal defenses available to it or other indemnified parties that
are different from or in addition to those available to the indemnifying party,
(ii) a conflict or potential conflict exists (based on the reasonable advice of
counsel to the indemnified party) between the indemnified party and the
indemnifying party (in which case the indemnifying party will not have the right
to direct the defense of such action on behalf of the indemnified party), or
(iii) the indemnifying party has not in fact employed counsel reasonably
satisfactory to the indemnified party to assume the defense of such action
within a reasonable time after receiving notice of the commencement of the
action, the indemnified party shall have the right to employ a single counsel to
represent it in any claim in respect of which indemnity may be sought under
subsection (a) or (b) of this Section 8, in which event the reasonable,
documented, out of pocket fees and expenses of such separate counsel shall be
borne by the indemnifying party or parties and reimbursed to the indemnified
party as incurred.  Notwithstanding anything to the contrary in this
Section 8, in no event shall an indemnifying party be required to pay fees and
expenses for more than one firm of attorneys (and local counsel) representing
all indemnified parties.

     

    Notwithstanding
anything to the contrary in this Section 8, the indemnifying party under this
Section 8 shall not be liable for any settlement of any proceeding effected
without its written consent (not to be unreasonably withheld), but if settled
with such consent or if there be a final judgment for the plaintiff, the
indemnifying party agrees to indemnify the indemnified party against any loss,
claim, damage, liability or expense by reason of such settlement or
judgment.  No indemnifying party shall, without the prior written
consent of the indemnified party (not to be unreasonably withheld), effect any
settlement, compromise or consent to the entry of judgment in any pending or
threatened action, suit or proceeding in respect of which any indemnified party
is a party or could be named and indemnity was or would be sought hereunder by
such indemnified party, unless such settlement, compromise or consent (a)
includes an unconditional release of such indemnified party from all liability
for claims that are the subject matter of such action, suit or proceeding and
(b) does not include a statement as to or an admission of fault, culpability or
a failure to act by or on behalf of any indemnified party.

     

    
      
         

      

      
        15

        
          

        

      

      
         

      

    

    (c)           If
the indemnification provided for in this Section 8 is unavailable or
insufficient to hold harmless an indemnified party under subsection (a) or (b),
above, then each indemnifying party shall contribute to the amount paid or
payable by such indemnified party as a result of the losses, claims, damages or
liabilities referred to in subsection (a) or (b) above, (i) in such proportion
as is appropriate to reflect the relative benefits received by the Company, on
the one hand, and Roth, on the other hand, from the Offering of the Shares or
(ii) if the allocation provided by clause (i) above is not permitted by
applicable law, in such proportion as is appropriate to reflect not only the
relative benefits referred to in clause (i) above but also the relative fault of
the Company, on the one hand, and Roth, on the other hand, in connection with
the statements or omissions that resulted in such losses, claims, damages or
liabilities, as well as any other relevant equitable
considerations.  The relative benefits received by the Company, on the
one hand, and Roth, on the other hand, shall be deemed to be in the same
proportion as the total net proceeds from the Offering (before deducting
expenses) received by the Company, and the total placement agent fees received
by Roth, in each case as set forth on the cover page of the Final Prospectus,
bear to the aggregate offering price of the Shares set forth on such
cover.  The relative fault shall be determined by reference to, among
other things, whether the untrue or alleged untrue statement of a material fact
or the omission or alleged omission to state a material fact relates to
information supplied by the Company or Roth and the parties’ relevant intent,
knowledge, access to information and opportunity to correct or prevent such
untrue statement or omission.  The Company and Roth agree that it
would not be just and equitable if contributions pursuant to this subsection (d)
were to be determined by pro rata allocation or by any other method of
allocation that does not take account of the equitable considerations referred
to in the first sentence of this subsection (d).  The amount paid by
an indemnified party as a result of the losses, claims, damages or liabilities
referred to in the first sentence of this subsection (d) shall be deemed to
include any legal or other expenses reasonably incurred by such indemnified
party in connection with investigating or defending against any action or claim
that is the subject of this subsection (d).  Notwithstanding the
provisions of this subsection (d), Roth shall not be required
to contribute any amount in excess of the amount of Roth’s placement agent
fees actually received by Roth from the Offering of the
Shares.  No person guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the Securities Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent
misrepresentation.

     

    (d)           The
benefits of the obligations of the Company under this Section 8 shall extend,
upon the same terms and conditions, to each person, if any, who controls Roth
within the meaning of Section 15 of the Securities Act or Section 20 of the
Exchange Act; and the benefits of the obligations of Roth under this Section 8
shall extend, upon the same terms and conditions, to the Company, and its
officers, directors and each person who controls the Company within the meaning
of Section 15 of the Securities Act or Section 20 of the Exchange
Act.

     

    (e)           For
purposes of this Agreement, Roth confirms, and the Company acknowledges, that
there is no information concerning Roth furnished in writing to the Company by
Roth specifically for preparation of or inclusion in the Registration Statement,
the Time of Sale Disclosure Package or the Final Prospectus, other than the
statements regarding Roth set forth in the “Plan of Distribution” section of the
Final Prospectus and Time of Sale Disclosure Package, only insofar as such
statement relate to the amount of selling concession and related activities that
may be undertaken by Roth.

     

    
      
         

      

      
        16

        
          

        

      

      
         

      

    

    9.           Representations
and Agreements to Survive Delivery.  All representations,
warranties, and agreements of the Company herein or in certificates delivered
pursuant hereto including, but not limited to, the agreements of Roth and the
Company contained in the second to last sentence of Section 1, Section 6(h) and
Section 8 hereof, shall remain operative and in full force and effect regardless
of any investigation made by or on behalf of Roth or any controlling person
thereof, or the Company or any of its officers, directors, or controlling
persons, and shall survive delivery of, and payment for, the Shares to and by
Roth hereunder.

     

    10.         Notices.  Except
as otherwise provided herein, all communications hereunder shall be in writing
and, if to Roth, shall be mailed, delivered or telecopied to Roth Capital
Partners, LLC, 24 Corporate Plaza, Newport Beach, CA, telecopy number: (949)
720-7227, Attention:  Aaron Gurewitz with a copy (which shall not
constitute notice) to Winston & Strawn LLP (US), 200 Park Avenue, New York,
New York 10166, Attention: Eric L. Cohen; and if to the Company, shall be
mailed, delivered or telecopied to it at China Ritar Power Corp., Room 405,
Tower C, Huahan Building, 16 Langshan Road, North High-Tech Industrial Park,
Nanshan District, Shenzhen, China, 518057, Telephone: (86) 755-83475380,
Attention: Chief Executive Officer, with a copy (which shall not constitute
notice) to The
Crone Law Group, 101
Montgomery Street, Suite 1950,
San Francisco, CA 94104, Facsimile:  (415)
955-8910, Attn.:  Mark Crone, Esq., or in each case to such other
address as the person to be notified may have requested in
writing.  Any party to this Agreement may change such address for
notices by sending to the parties to this Agreement written notice of a new
address for such purpose.

     

    11.         Persons Entitled
to Benefit of Agreement.  This Agreement shall inure solely to
the benefit of and be binding upon the parties hereto and their respective
successors and assigns and the controlling persons, officers and directors
referred to in Section 8.  Nothing in this Agreement is intended or
shall be construed to give to any other person, firm or corporation any legal or
equitable remedy or claim under or in respect of this Agreement or any provision
herein contained.

     

    12.         Absence of
Fiduciary Relationship.  The Company acknowledges and agrees
that: (a) Roth has been retained solely to act as placement agent in connection
with the sale of the Shares and that no fiduciary, advisory or agency
relationship between the Company and Roth has been created in respect of any of
the transactions contemplated by this Agreement, irrespective of whether Roth
has advised or is advising the Company on other matters; (b) the price and other
terms of the Shares set forth in this Agreement were established by Roth and the
Investors following discussions and arms-length negotiations and the Company is
capable of evaluating and understanding and understands and accepts the terms,
risks and conditions of the transactions contemplated by this Agreement; (c) it
has been advised that Roth and its affiliates are engaged in a broad range of
transactions that may involve interests that differ from those of the Company
and that Roth has no obligation to disclose such interest and transactions to
the Company by virtue of any fiduciary, advisory or agency relationship; (d) it
has been advised that Roth is acting, in respect of the transactions
contemplated by this Agreement, solely for the benefit of Roth, and not on
behalf of the Company.

     

    13.         No
Limitations.  Nothing in this Agreement shall be construed to
limit the ability of Roth or its affiliates to (a) trade in the Company’s or any
other company’s securities or publish research on the Company or any other
company, subject to applicable law, or (b) pursue or engage in investment
banking, financial advisory or other business relationships with entities that
may be engaged in or contemplate engaging in, or acquiring or disposing of,
businesses that are similar to or competitive with the business of the
Company.

     

    
      
         

      

      
        17

        
          

        

      

      
         

      

    

    14.         Amendments and
Waivers.  No supplement, modification or waiver of this
Agreement shall be binding unless executed in writing by the party to be bound
thereby.  The failure of a party to exercise any right or remedy shall
not be deemed or constitute a waiver of such right or remedy in the
future.  No waiver of any of the provisions of this Agreement shall be
deemed or shall constitute a waiver of any other provision hereof (regardless of
whether similar), nor shall any such waiver be deemed or constitute a continuing
waiver unless otherwise expressly provided.

     

    15.         Partial
Unenforceability.  The invalidity or unenforceability of any
section, paragraph, clause or provision of this Agreement shall not affect the
validity or enforceability of any other section, paragraph, clause or
provision.

     

    16.        Governing
Law.  This Agreement shall be governed by and construed in
accordance with the laws of the State of New York.

     

    17.        Counterparts.  This
Agreement may be executed and delivered (including by facsimile transmission and
electronic mail attaching a portable document file (.pdf)) in one or more
counterparts and, if executed and delivered in more than one counterpart, the
executed counterparts shall each be deemed to be an original and all such
counterparts shall together constitute one and the same instrument.

     

    
      
         

      

      
        18

        
          

        

      

      
         

      

    

    Please
sign and return to the Company the enclosed duplicates of this letter whereupon
this letter will become a binding agreement between the Company and Roth in
accordance with its terms.

     

    
      
        	
                Very
      truly yours,

              
	 
      
	
                CHINA
      RITAR POWER CORP.

              
	 
      	 
      
	
                By:

              	
                /s/ Jiada Hu

              
	
                Name:  

              	
                Jiada Hu

              
	
                Title:

              	
                Chief Executive
  Officer

              

      

    

    

    
      
        	
                Confirmed
      as of the date first above-

                mentioned
      by Roth.

              
	 
      
	
                ROTH
      CAPITAL PARTNERS, LLC

              
	 
      	 
      
	
                By:

              	
                /s/ Aaron M. Gurewitz

              
	
                Name:  

              	
                Aaron M. Gurewitz

              
	
                Title:

              	
                Head of Equity Capital
    Markets

              

      

    

     

    
      
         

      

      
        19SUBSCRIPTION
AGREEMENT

     

    This
subscription agreement (this “Subscription
Agreement”) is dated October 2, 2009, by and between the investor
identified on the signature page hereto (“Investor”), and China
Ritar Power Corp., a Nevada corporation (the “Company”), whereby
the parties agree as follows:

     

    
      	
              1.

            	
              Subscription.

            

    

     

    
      	
               
      

            	
              a)

            	
              Investor
      agrees to buy and the Company agrees to sell and issue to Investor such
      number of shares of the Company’s common stock, $0.001 par value per share
      (the “Common
      Stock”), set forth on the signature page hereto for the aggregate
      purchase price set forth on the signature page hereto (the “Purchase
      Price”).  The shares of Common Stock to be issued to
      Investor are hereinafter referred to as the “Shares”.

            

    

     

    
      	
               
      

            	
              b)

            	
              The
      Shares have been registered on a Form S-3, File No. 333-161281, which
      registration statement (the “Registration
      Statement”) has been declared effective by the Securities and
      Exchange Commission, has remained effective since such date and is
      effective on the date hereof.  The Shares are being issued in
      connection with an offering (the “Offering”)
      described in a Prospectus Supplement dated October 5, 2009, along with the
      Base Prospectus dated August 21, 2009, which has been delivered to the
      Investor (collectively, the “Prospectus”).

            

    

     

    
      	
               
      

            	
              c)

            	
              On
      October 8, 2009 (the “Closing Date”),
      in accordance with Rule 15c6-1 promulgated under the Securities Exchange
      Act of 1934, as amended, and subject to the satisfaction or waiver of all
      of the closing conditions set forth in the Placement Agency Agreement (the
      “Placement
      Agreement”), dated October 2, 2009, by and among the Company and
      the placement agent named therein (the “Placement
      Agent”), the Placement Agent will disburse, or cause to be
      disbursed, to the Company an amount equal to the Purchase Price for such
      Shares, less its commissions and reimbursable expenses.  Upon
      receipt of such disbursement by the Company and the Placement Agent, the
      Company shall immediately cause the Shares to be delivered directly to
      Investor. The transfer of the Shares shall be made through the facilities
      of The Depository Trust Company’s DWAC system in accordance with the
      instructions set forth on the signature page attached hereto under the
      heading “DWAC Instructions.”

            

    

     

    
      
         

      

      
        
        

        
          

        

      

      
         

      

    

    2.           Company Representations and
Warranties.  The Placement Agreement contains representations,
warranties, covenants and agreements of the Company that may be relied upon by
the Investor, which shall be a third party beneficiary of the representations
and warranties contained therein.  The
Company confirms that neither it nor any other person acting on its behalf has
provided the Investor or their agents or counsel with any information that
constitutes or could reasonably be expected to constitute material, nonpublic
information, except as will be disclosed in the Prospectus and the Company’s
press release and Form 8-K filed with the Commission in connection with the
Offering.  The Company understands and confirms that the Investor will
rely on the foregoing in effecting transactions in securities of the
Company.  In addition to and without limiting the foregoing,
the Company represents and warrants that: (a) it has full right, power
and authority to enter into this Subscription Agreement and to perform all of
its obligations hereunder; (b) this Subscription Agreement has been duly
authorized and executed by and constitutes a valid and binding agreement of the
Company enforceable in accordance with its terms, except as such enforceability
may be limited by bankruptcy, insolvency, reorganization, moratorium or similar
laws affecting the rights and remedies of creditors generally; (c) the execution
and delivery of this Subscription Agreement and the consummation of the
transactions contemplated hereby do not conflict with or result in a breach of
(i) the Company’s articles of incorporation or by-laws, or (ii) any material
agreement or any law or regulation to which the Company is a party or by which
any of its property or assets is bound; (d) the Shares have been duly authorized
for sale and issuance, and when issued and delivered, will be validly issued,
fully paid and nonassessable; (e) the Registration Statement and any
post-effective amendment thereto filed pursuant to the Securities Act of 1933,
as amended (the “Securities Act”), at
the time it became effective, did not contain any untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary
to make the statements therein not misleading; (f) the Prospectus did not
contain as of its respective date, and as of the date hereof does not contain,
and on the Closing Date will not contain, any untrue statement of a material
fact or omit to state a material fact necessary in order to make the statements
therein, in light of the circumstances under which they were made, not
misleading; and (g) all preemptive rights or rights of first refusal held by
stockholders of the Company and applicable to the transactions contemplated
hereby, if any, have been duly satisfied or waived in accordance with the terms
of the agreements between the Company and such stockholders conferring such
rights.

     

    3.      Investor Representations,
Warranties and Acknowledgments.  Investor represents and
warrants that: (a) it has full right, power and authority to enter into this
Subscription Agreement and to perform all of its obligations hereunder; (b) this
Subscription Agreement has been duly authorized and executed by and constitutes
a valid and binding agreement of Investor enforceable in accordance with its
terms, except as such enforceability may be limited by bankruptcy, insolvency,
reorganization, moratorium or similar laws affecting the rights and remedies of
creditors generally; (c) the execution and delivery of this Subscription
Agreement and the consummation of the transactions contemplated hereby do not
conflict with or result in a breach of (i) Investor’s certificate of
incorporation or by-laws (or other similar governing documents), or (ii) any
material agreement or any law or regulation to which Investor is a party or by
which any of its property or assets is bound; and (d) prior to the execution
hereof, Investor has had full access to and relied only upon (i) the Base
Prospectus, (ii) any prospectus supplements to the Base Prospectus, including in
each case information incorporated by reference therein, and (iii) the pricing,
placement agency and expense information contained in this
Agreement.  The Investor further acknowledges that other investors
(“Other
Investors”) are concurrently entering into subscription agreements in
substantially the same form as this Subscription Agreement as part of the
Offering.

     

    4.      Company
Covenants.  The Company and the Investor agree that the Company
shall, prior to the opening of the financial markets in New York City on the
business day immediately after the date hereof, issue a press release announcing
the Offering and disclosing all material information regarding the Offering,
unless this Subscription Agreement is executed by the parties hereto during the
regular trading hours of the financial markets in New York City, in which case
such press release shall be issued prior to the close of the financial markets
on the date hereof if reasonably feasible, but in no event will such press
release be issued before the last Subscription Agreement relating to the
Offering has been executed by the Company and the applicable Other
Investor.

     

    
      
         

      

      
        -2-

        
          

        

      

      
         

      

    

    5.      Conditions to the Company’s
Obligations.  In addition to any other conditions set forth
herein, the Company’s obligation to issue and sell the Shares to the Investor
shall be subject to: (a) the receipt by the Company of the Purchase Price for
the Shares being purchased hereunder as set forth on the Signature Page and (b)
the accuracy in all material respects of the representations and warranties made
by the Investor and the fulfillment of those undertakings of the Investor to be
fulfilled prior to the Closing Date.

     

    6.      Conditions to the Investor’s
Obligations.  In addition to any other conditions set forth herein,
the Investor’s obligation to purchase the Shares will be subject to (a) the
condition that the Placement Agent shall not have terminated the Placement
Agreement pursuant to the terms thereof, (b) the satisfaction in all material
respects of the conditions to the Placement Agent’s obligation to closing in the
Placement Agreement, and (c) the accuracy in all material respects of the
representations and warranties made by the Company and the fulfillment of those
undertakings of the Company to be fulfilled prior to the Closing Date.  The
Investor’s obligations are not conditioned on the purchase of Common Stock by
the Other Investors in the Offering. 

     

    7.      Miscellaneous.

     

    
      	
               
      

            	
              a)

            	
              Roth
      Capital Partners, LLC is serving as placement agent in this transaction
      and consummation of the transaction is subject to the terms and conditions
      of the Placement Agreement. 

            

    

     

    
      	
               
      

            	
              b)

            	
              Except
      as otherwise provided herein, this Subscription Agreement constitutes the
      entire understanding and agreement between the parties with respect to its
      subject matter and there are no agreements or understandings with respect
      to the subject matter hereof which are not contained in this Subscription
      Agreement.  This Subscription Agreement may be modified only in
      writing signed by the parties
hereto.

            

    

     

    
      	
               
      

            	
              c)

            	
              In
      the event that the Placement Agreement is terminated by the Placement
      Agent prior to the closing to occur on the Closing Date pursuant to the
      terms thereof, this Agreement shall terminate without any further action
      or liability on the part of the parties
hereto.

            

    

     

    
      	
               
      

            	
              d)

            	
              This
      Subscription Agreement may be executed in any number of counterparts, all
      of which taken together shall constitute one and the same instrument and
      shall become effective when counterparts have been signed by each party
      and delivered to the other parties hereto, it being understood that all
      parties need not sign the same counterpart.  Execution may be
      made by delivery by facsimile or
PDF.

            

    

     

    
      
         

      

      
        -3-

        
          

        

      

      
         

      

    

    
      	
               
      

            	
              e)

            	
              The
      provisions of this Subscription Agreement are severable and, in the event
      that any court or officials of any regulatory agency of competent
      jurisdiction shall determine that any one or more of the provisions or
      part of the provisions contained in this Subscription shall, for any
      reason, be held to be invalid, illegal or unenforceable in any respect,
      such invalidity, illegality or unenforceability shall not affect any other
      provision or part of a provision of this Subscription Agreement and this
      Subscription Agreement shall be reformed and construed as if such invalid
      or illegal or unenforceable provision, or part of such provision, had
      never been contained herein, so that such provisions would be valid, legal
      and enforceable to the maximum extent possible, so long as such
      construction does not materially adversely effect the economic rights of
      either party hereto.

            

    

     

    
      	
               
      

            	
              f)

            	
              All
      communications hereunder shall be in writing and shall be mailed, hand
      delivered, sent by a recognized overnight courier service such as Federal
      Express, or sent via facsimile and confirmed by letter, to the party to
      whom it is addressed at the following addresses or such other address as
      such party may advise the other in
writing:

            

    

     

    To the
Company:  as set forth on the signature page hereto.

     

    To the
Investor:  as set forth on the signature page hereto.

     

    All
notices hereunder shall be effective upon receipt by the party to which it is
addressed.

     

    
      	
               
      

            	
              g)

            	
              This
      Agreement shall be governed by and interpreted in accordance with the laws
      of the State of New York for contracts to be wholly performed in such
      state and without giving effect to the principles thereof regarding the
      conflict of laws.  To the extent determined by such court, the
      prevailing party shall reimburse the other party for any reasonable legal
      fees and disbursements incurred in enforcement of, or protection of any of
      its rights under this Agreement.

            

    

     

    *****

    

    
      
         

      

      
        -4-

        
          

        

      

      
         

      

    

     

    If the
foregoing correctly sets forth our agreement, please confirm this by signing and
returning to us the duplicate copy of this letter.

     

    
      
        	
                COMPANY:

              
	 
      
	
                CHINA
      RITAR POWER CORP.

              
	 
      	 
      
	
                By:

              	
                  

              
	
                Name:

              	
                  

              
	
                Its:

              	
                  

              

      

    

    

    Address for
Notice:

    

    China
Ritar Power Corp.

    

    Room 405,
Tower C, Huahan Building,

    16
Langshan Road, North High-Tech Industrial Park,

    Nanshan
District,

    Shenzhen,
China, 518057

    Attention:
Chief Executive Officer

    Telephone:
(86) 755-83475380

    

    With a
copy to:

    

    The Crone
Law Group

    101
Montgomery Street, Suite 1950

    San
Francisco, CA 94104

    Facsimile:  (415)
955-8910

    Attn.:  Mark
Crone, Esq.

    

    Wire
Instructions:

    
      
         

      

      
        
        

        
          

        

      

      
         

      

    

    INVESTOR:

     

    
      
        	
                Number of
      Shares:____________

              	 
      	
                By:

              	
                   

              
	 
      	 
      	
                Name:

              	
                  

              
	
                Purchase Price per
      Share:______

              	 
      	
                Its:

              	
                  

              
	 
      	 
      	 
      	 
      
	
                Aggregate Purchase
      Price:______

              	 
      	 
      	 
      

      

    

     

    Name and address for
notice:

     

    DWAC
Instructions:

    Name of
DTC Participant:

    DTC
Participant Number:

    Account
Number:

     

    
      
         

      

      
        -6-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00163-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00163-of-00352.parquet"}]]